Market Overview:
The global thyroid cancer treatment market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of thyroid cancer, rising awareness about available treatments, and technological advancements in the field of thyroid cancer treatment. The global thyroid cancer treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into surgery, iodine therapy, external radiotherapy, thyroxin treatment chemotherapy drugs and others. On the basis of application; hospitals are expected to account for a major share in terms of revenue followed by oncology centers and hospital pharmacies during 2018-2030 owing to increase in number os patients diagnosed with Thyroid Cancer across globe .Retail pharmacies are also anticipated witness significant growth due high adoption rate for self-medication by patients suffering from Thyroid Cancer across different regions during forecast period .Geographically North America dominates global Thyroid Cancer Treatment Market followed by Europe Asia Pacific while MEA region is projected exhibit highest CAGR over forecast period .Some key players operating in this market include F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Bristol Myers Squibb Company Merck & Co., Inc.
Product Definition:
The thyroid is a small gland in the neck that makes hormones that help control the body's metabolism. Thyroid cancer is a type of cancer that starts in the thyroid gland.
There are different types of thyroid cancer, but most are treated with surgery to remove the thyroid gland. If the cancer has spread to other parts of the body, radiation therapy or chemotherapy may also be used.
Surgery:
Thyroid cancer is one of the most common cancers in the world. It accounted for nearly 1.0% of all cancers worldwide in 2018 and approximately 90,000 new cases are diagnosed each year. Thyroid cancer generally affects older adults; however, it can occur at any age group.
Iodine Therapy:
Iodine is a halogen element that has one electron pair and is therefore reactive with oxygen. Iodine (ID) therapy includes the administration of ID to cancer patients as an anti-neoplastic agent. It specifically targets and damages the cancerous cells, thereby causing harm to the tumor without affecting healthy tissues. The thyroid hormones are produced in response to signals from the brain, which controls iodine uptake by cells in the thyroid gland.
Application Insights:
The oncology centers segment dominated the global thyroid cancer treatment market in 2017. This can be attributed to factors such as availability of a large number of treatment options, presence of well-established healthcare infrastructure, and high prevalence of cancer in various regions. For instance, according to data published by WHO in 2018, around 1 million people are diagnosed with thyroid cancer every year worldwide.
External radiotherapy is the second-line therapy for most patients with papillary carcinoma or follicular carcinoma who cannot undergo surgery or cannot have surgery again due to recurrence risk. Thus, increasing incidences of advanced cancers coupled with limited treatment options available for them is expected to drive growth over the forecast period.
Drugs are expected to witness significant growth during the forecast period owing to advancements made in chemotherapy and hormonal therapy that have led towards reduced mortality rates among patients suffering from metastatic disease as well as locally advanced or metastatic tumors that cannot be treated through surgery alone.
Regional Analysis:
North America dominated the global thyroid cancer treatment market in 2017. This can be attributed to the presence of key players, availability of technologically advanced products, high healthcare expenditure and favorable reimbursement policies. The U.S.
Asia Pacific is expected to register lucrative growth over the forecast period due to rising disposable income resulting in improved access & quality of life issues that prompt people with thyroid cancer symptoms or diagnosed previously for instance iodine deficiency disorders such as goiters & endemic cretinism among others have been observed in developing countries like India thus increasing demand for thyroxin drugs.
Growth Factors:
- Rising incidence of thyroid cancer
- Increasing awareness about thyroid cancer treatment options
- Growing demand for minimally invasive procedures for thyroid cancer treatment
- Technological advancements in thyroid cancer treatment procedures
- Availability of affordable and innovative treatments for thyroid cancer
Scope Of The Report
Report Attributes
Report Details
Report Title
Thyroid Cancer Treatment Market Research Report
By Type
Surgery, Iodine Therapy, External Radiotherapy, Thyroxin Treatment, Chemotherapy, Drugs
By Application
Hospitals, Oncology centers, Hospital Pharmacies, Retail Pharmacies
By Companies
Baxter, Mylan, Alara, Bristol Myers, Abbott, Teva, App pharmaceuticals, Jerome Stevens
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
140
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global Thyroid Cancer Treatment Market Report Segments:
The global Thyroid Cancer Treatment market is segmented on the basis of:
Types
Surgery, Iodine Therapy, External Radiotherapy, Thyroxin Treatment, Chemotherapy, Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Oncology centers, Hospital Pharmacies, Retail Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Baxter
- Mylan
- Alara
- Bristol Myers
- Abbott
- Teva
- App pharmaceuticals
- Jerome Stevens
Highlights of The Thyroid Cancer Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Surgery
- Iodine Therapy
- External Radiotherapy
- Thyroxin Treatment
- Chemotherapy
- Drugs
- By Application:
- Hospitals
- Oncology centers
- Hospital Pharmacies
- Retail Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Thyroid Cancer Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The thyroid cancer treatment options depend on the type of thyroid cancer and its stage. Treatment may include surgery, radiation therapy, chemotherapy, or a combination of these treatments.
Some of the major players in the thyroid cancer treatment market are Baxter, Mylan, Alara, Bristol Myers, Abbott, Teva, App pharmaceuticals, Jerome Stevens.
The thyroid cancer treatment market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Thyroid Cancer Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Thyroid Cancer Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Thyroid Cancer Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Thyroid Cancer Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Thyroid Cancer Treatment Market Size & Forecast, 2018-2028
4.5.1 Thyroid Cancer Treatment Market Size and Y-o-Y Growth
4.5.2 Thyroid Cancer Treatment Market Absolute $ Opportunity
Chapter 5 Global Thyroid Cancer Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Thyroid Cancer Treatment Market Size Forecast by Type
5.2.1 Surgery
5.2.2 Iodine Therapy
5.2.3 External Radiotherapy
5.2.4 Thyroxin Treatment
5.2.5 Chemotherapy
5.2.6 Drugs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Thyroid Cancer Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Thyroid Cancer Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Oncology centers
6.2.3 Hospital Pharmacies
6.2.4 Retail Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Thyroid Cancer Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Thyroid Cancer Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Thyroid Cancer Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Thyroid Cancer Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Thyroid Cancer Treatment Market Size Forecast by Type
9.6.1 Surgery
9.6.2 Iodine Therapy
9.6.3 External Radiotherapy
9.6.4 Thyroxin Treatment
9.6.5 Chemotherapy
9.6.6 Drugs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Thyroid Cancer Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Oncology centers
9.10.3 Hospital Pharmacies
9.10.4 Retail Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Thyroid Cancer Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Thyroid Cancer Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Thyroid Cancer Treatment Market Size Forecast by Type
10.6.1 Surgery
10.6.2 Iodine Therapy
10.6.3 External Radiotherapy
10.6.4 Thyroxin Treatment
10.6.5 Chemotherapy
10.6.6 Drugs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Thyroid Cancer Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Oncology centers
10.10.3 Hospital Pharmacies
10.10.4 Retail Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Thyroid Cancer Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Thyroid Cancer Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Thyroid Cancer Treatment Market Size Forecast by Type
11.6.1 Surgery
11.6.2 Iodine Therapy
11.6.3 External Radiotherapy
11.6.4 Thyroxin Treatment
11.6.5 Chemotherapy
11.6.6 Drugs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Thyroid Cancer Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Oncology centers
11.10.3 Hospital Pharmacies
11.10.4 Retail Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Thyroid Cancer Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Thyroid Cancer Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Thyroid Cancer Treatment Market Size Forecast by Type
12.6.1 Surgery
12.6.2 Iodine Therapy
12.6.3 External Radiotherapy
12.6.4 Thyroxin Treatment
12.6.5 Chemotherapy
12.6.6 Drugs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Thyroid Cancer Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Oncology centers
12.10.3 Hospital Pharmacies
12.10.4 Retail Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Thyroid Cancer Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Thyroid Cancer Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Thyroid Cancer Treatment Market Size Forecast by Type
13.6.1 Surgery
13.6.2 Iodine Therapy
13.6.3 External Radiotherapy
13.6.4 Thyroxin Treatment
13.6.5 Chemotherapy
13.6.6 Drugs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Thyroid Cancer Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Oncology centers
13.10.3 Hospital Pharmacies
13.10.4 Retail Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Thyroid Cancer Treatment Market: Competitive Dashboard
14.2 Global Thyroid Cancer Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Baxter
14.3.2 Mylan
14.3.3 Alara
14.3.4 Bristol Myers
14.3.5 Abbott
14.3.6 Teva
14.3.7 App pharmaceuticals
14.3.8 Jerome Stevens
